<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> frequently exhibit loss of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes or allelic gains of activated oncogenes </plain></SENT>
<SENT sid="1" pm="."><plain>A significant proportion of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility loci in the mouse show somatic losses or gains consistent with the presence of a <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> susceptibility or resistance allele </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, allele-specific somatic gains or losses at loci may demarcate the presence of resistance or susceptibility alleles </plain></SENT>
<SENT sid="3" pm="."><plain>The goal of this study was to determine if previously mapped susceptibility loci for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> show evidence of allele-specific somatic events in <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: We performed quantitative genotyping of 16 single nucleotide polymorphisms (SNPs) showing statistically significant association with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> in published genome-wide association studies (GWAS) </plain></SENT>
<SENT sid="5" pm="."><plain>We genotyped 194 paired <z:mpath ids='MPATH_458'>normal</z:mpath> and <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> DNA samples and 296 paired validation samples to investigate these SNPs for allele-specific somatic gains and losses </plain></SENT>
<SENT sid="6" pm="."><plain>We combined analysis of our data with published data for seven of these SNPs </plain></SENT>
<SENT sid="7" pm="."><plain>RESULTS: No statistically significant evidence for allele-specific somatic selection was observed for the tested polymorphisms in the discovery set </plain></SENT>
<SENT sid="8" pm="."><plain>The rs6983267 variant, which has shown preferential loss of the non-risk T allele and relative gain of the risk G allele in previous studies, favored relative gain of the G allele in the combined discovery and validation samples (corrected p-value = 0.03) </plain></SENT>
<SENT sid="9" pm="."><plain>When we combined our data with published allele-specific imbalance data for this SNP, the G allele of rs6983267 showed statistically significant evidence of relative retention (p-value = 2.06×10(-4)) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Our results suggest that the majority of variants identified as <z:hpo ids='HP_0003003'>colon cancer</z:hpo> susceptibility alleles through GWAS do not exhibit somatic allele-specific imbalance in <z:e sem="disease" ids="C0009375" disease_type="Neoplastic Process" abbrv="">colon tumors</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>Our data confirm previously published results showing allele-specific imbalance for rs6983267 </plain></SENT>
<SENT sid="12" pm="."><plain>These results indicate that allele-specific imbalance of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> susceptibility alleles may not be a common phenomenon in <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>